Relief Therapeutics Holding AG (RLFTF)

[DonDonDonDon]

RLFTF and CYDY are pursuing headlines in poor countries. It is probably because they realize that they won't be getting an EUA or revenue anytime soon. HGEN, on the other hand, should be getting an EUA for Covid sometime in May. HGEN is green for the 6th day in a row.

HGEN's recent CAR-T news is even more exciting than their Covid news. CAR-T therapy has been hampered by GM-CSF causing toxicity issues. HGEN's lenzilumab eliminates those toxicities. HGEN owns the patent to using anti-GM-CSF in conjunction with CAR-T treatments. Every Big Pharma has CAR-T therapies that need lenzilumab in order to work. A bidding war will certainly happen.

https://www.targetedonc.com/view/lenzilumab-plus-axi-cel-achieves-responses-in-100-of-patients-with-dlbcl-with-limited-toxicity-in-small-study